HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Justin L Ricker Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2015Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial.
11/2013Exposure-response (safety) analysis to identify linifanib dose for a Phase III study in patients with hepatocellular carcinoma.
1/2013Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Justin L Ricker Research Topics

Disease

10Neoplasms (Cancer)
11/2015 - 12/2004
5Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2010 - 01/2007
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2015 - 10/2008
4Anorexia
01/2010 - 12/2006
3Hepatocellular Carcinoma (Hepatoma)
01/2015 - 01/2013
3Diarrhea
11/2013 - 08/2011
3Hypertension (High Blood Pressure)
11/2013 - 08/2011
3Fatigue
01/2013 - 12/2006
3Squamous Cell Carcinoma of Head and Neck
07/2008 - 12/2004
3Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
11/2002 - 10/2000
2Lymphoma (Lymphomas)
10/2016 - 01/2010
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2015 - 02/2008
2Thrombocytopenia (Thrombopenia)
09/2014 - 12/2009
2Colorectal Neoplasms (Colorectal Cancer)
09/2014 - 10/2008
2Proteinuria
11/2013 - 08/2011
2Nausea
08/2011 - 12/2006
2Mycosis Fungoides
12/2009 - 07/2007
2Disease Progression
10/2008 - 07/2007
2Head and Neck Neoplasms (Head and Neck Cancer)
07/2008 - 02/2008
2Carcinogenesis
10/2007 - 09/2004
2Pruritus (Itching)
07/2007 - 01/2007
1B-Cell Leukemia (Leukemia, B Cell)
10/2016
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2016
1Hematologic Neoplasms (Hematological Malignancy)
08/2015
1Hypothyroidism
09/2014
1Asthenia
11/2013
1Hepatitis B
01/2013
1Renal Cell Carcinoma (Grawitz Tumor)
12/2011
1Hypokalemia
01/2010
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2010
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2010
1Pulmonary Embolism
12/2009
1Exanthema (Rash)
12/2009
1Leukemia
02/2008
1Inflammation (Inflammations)
10/2007
1Vomiting
12/2006
1Multiple Myeloma
12/2004
1Hypoxia (Hypoxemia)
12/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2004
1Cystic Kidney Diseases (Cystic Kidney Disease)
11/2002
1Pancreatic Cyst
11/2002
1Cysts
01/2002
1Body Weight (Weight, Body)
01/2002
1Renal Insufficiency (Renal Failure)
10/2000

Drug/Important Bio-Agent (IBA)

10linifanibIBA
11/2015 - 08/2011
8VorinostatFDA Link
01/2010 - 12/2006
7Histone Deacetylase InhibitorsIBA
01/2010 - 01/2007
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015 - 08/2011
4Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2015 - 08/2011
4Transcription Factors (Transcription Factor)IBA
07/2008 - 09/2004
3Paclitaxel (Taxol)FDA LinkGeneric
11/2015 - 12/2004
3NF-kappa B (NF-kB)IBA
07/2008 - 09/2004
3Messenger RNA (mRNA)IBA
11/2002 - 10/2000
2Carboplatin (JM8)FDA LinkGeneric
11/2015 - 02/2015
2Biomarkers (Surrogate Marker)IBA
11/2015 - 07/2008
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2015 - 07/2014
2Platelet-Derived Growth FactorIBA
02/2015 - 07/2014
2CreatinineIBA
12/2009 - 12/2006
2thiamine triphosphorate (TTP)IBA
07/2007 - 01/2007
2Epidermal Growth Factor (EGF)IBA
11/2002 - 10/2000
1venetoclaxIBA
10/2016
1Phosphotransferases (Kinase)IBA
08/2015
1Azacitidine (5 Azacytidine)FDA Link
08/2015
1ilorasertibIBA
08/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2015
1Aurora KinasesIBA
08/2015
1Sorafenib (BAY 43-9006)FDA Link
01/2015
1Bevacizumab (Avastin)FDA Link
09/2014
1Sunitinib (Sutent)FDA Link
12/2011
1Dihydrotachysterol (AT 10)IBA
07/2008
1Bortezomib (Velcade)FDA Link
07/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
07/2008
1thiazolyl blueIBA
07/2008
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2008
1Proteasome InhibitorsIBA
07/2008
1antineoplaston A10 (A 10)IBA
07/2007
1Caspase 3 (Caspase-3)IBA
12/2004
12-MethoxyestradiolIBA
12/2004
1Proteins (Proteins, Gene)FDA Link
11/2002
1AntibodiesIBA
11/2002
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2002
1Urea (Carbamide)FDA LinkGeneric
01/2002
1Antisense OligonucleotidesIBA
01/2002
1NitrogenIBA
01/2002
1ClusterinIBA
10/2000

Therapy/Procedure

8Therapeutics
01/2015 - 12/2004
3Drug Therapy (Chemotherapy)
10/2016 - 02/2008
1Aftercare (After-Treatment)
12/2009